Human MARK2 Stable Cell Line - HFF-1

Microtubule Affinity-Regulating Kinase 2 (MARK2) is a highly conserved serine/threonine protein kinase that plays an indispensable role in numerous fundamental cellular physiological processes. MARK2 initially garnered significant attention for its ability to efficiently phosphorylate microtubule-associated proteins (such as tau, MAP2, and MAP4). Through this action, it facilitates the rapid dissociation of these structural proteins from the microtubule cytoskeleton. This biochemical activity directly regulates microtubule dynamics, thereby triggering controlled cytoskeletal instability and reorganization processes. Beyond its canonical role in cytoskeletal remodeling, MARK2—often referred to in scientific literature as EMK1 or Par-1b—also serves as a central regulator of cellular polarity. It actively coordinates the asymmetric distribution of cellular components, a process critical for maintaining the integrity of epithelial tissues, guiding directional cell migration, and ensuring the proper differentiation of neurons. Dysregulation or mutation of the MARK2 gene is closely implicated in the pathogenesis of various severe human diseases. Of particular note, the aberrant hyperphosphorylation of the tau protein by MARK2 is one of the primary biochemical triggers leading to the formation of neurofibrillary tangles—pathological aggregates commonly observed in Alzheimer''s disease and other devastating neurodegenerative "tauopathies."

The "Human MARK2 Stable Cell Line," derived from the HFF-1 cell line, is an in vitro research model specifically engineered to advance the study of the complex biology surrounding the MARK2 kinase. HFF-1 cells are a widely validated human foreskin fibroblast line, renowned for their robust basal growth characteristics, normal diploid karyotype, and exceptional amenability to genetic manipulation. These intrinsic biological attributes render the HFF-1 cell line an ideal mammalian host background for establishing stable systems for gene integration and expression. The Human MARK2 Stable Cell Line is designed to ensure the stable, sustained overexpression—or precise regulatory control—of the human MARK2 protein. Crucially, this cell line maintains robust protein expression levels even after undergoing multiple consecutive passages, without compromising its phenotypic stability, cellular viability, or strict genetic integrity. This cell line product holds immense practical value for pharmaceutical laboratories engaged in the high-throughput screening of novel small-molecule kinase inhibitors, as well as for those evaluating potential neuroprotective therapies targeting Alzheimer''s disease and related dementias.